Molecular Weight:384.237 g/mol
Product description:Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsedmultiple myeloma and mantle cell lymphoma.
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: email@example.com
2. Tel: +86 592 536 5868
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: